Please login to the form below
patient enrolment
This page shows the latest patient enrolment news and features for those working in and with pharma, biotech and healthcare.
Biogen plans confirmatory trial as FDA documents show struggle over Aduhelm approval
patient population for Aduhelm of approximately one to two million people, according to the companies. ... to address pricing in order to achieve both patient access and support budget sustainability.”.
Latest news
-
RedHill Biopharma advances phase 2/3 COVID-19 programme
With the study now approved in the UK and Russia, and additional approvals expected in the coming weeks, patient enrolment is planned to commence later this month,” said Aida Bibliowicz, vice
-
Entering the era of digital trials
At the same time, the data explosion and emergence of automated analytical tools have raised expectations that the industry can crack the patient enrolment conundrum and other persistent problems. ... It is at this stage in the process that smartphone
-
Viking throws down gauntlet in NASH battle
The caveat of course is that the two trials have different enrolment criteria and patient baseline characteristics – in fact Madrigal’s trial was much bigger with around 150 patients versus
-
Merck suspends two Keytruda trials after patient deaths
Investigators to look at Keytruda with Pomalyst and Revlimid. Merck &Co has paused patient enrolment in two trials of Keytruda to allow investigators to explore reports of deaths among patients taking
-
Trials of AZ's durvalumab restart as FDA hold is relaxed
Patient recruitment can restart in two trials of AstraZeneca's PD-L1 inhibitor durvalumab placed under temporary suspension by the FDA, says the company. ... The phase III KESTREL trial has already re-opened for new patient enrolment at some clinical
RedHill Biopharma advances phase 2/3 COVID-19 programme
Entering the era of digital trials
Viking throws down gauntlet in NASH battle
Merck suspends two Keytruda trials after patient deaths
Trials of AZ's durvalumab restart as FDA hold is relaxed
More from news
Approximately 1 fully matching, plus 33 partially matching documents found.
Latest Intelligence
-
How early-stage clinical research is facilitating the new wave of personalised medicines
One of these adaptations relates to patient enrolment. Whereas previously CROs were able to draw on a wide-ranging patient cohort for firstin-human studies, gene editing studies require a cohort ... to the target patient population and that adaptive
-
Transforming clinical trial data into a long-term asset
Having experienced the disruption caused by the pandemic, 51% identified a need for more diversification of patient enrolment, for instance, by expanding the scope of trials beyond just one city, country ... Trial data in a digitised world. As the role
-
Encouraging patient participation in real-world studies
plc, we explore the intersection between real-word studies and patient participation in drug development. ... Listening to patients should always be part of protocol design to minimise the patient burden, increase enrolment and bolster retention.
-
Streamlining clinical trials – why better data use is key
Investment in patient enrolment and fulfilling compliance requirements are likely to remain staples of clinical drug trials – and for good reason. ... endpoints and patient safety, which can lead to better data, faster enrolment and reduced patient
-
The trials and tribulations of rare opportunities
Patient eligibility criteria can also impact patient enrolment. “When studying potential disease-modifying therapies, there is often a desire from study sponsors to enroll patients in the early stages of the ... Patient-centricity is also core to
How early-stage clinical research is facilitating the new wave of personalised medicines
Transforming clinical trial data into a long-term asset
Encouraging patient participation in real-world studies
Streamlining clinical trials – why better data use is key
The trials and tribulations of rare opportunities
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Latest from PMHub
-
Key benefits of a digital patient recruitment solution
Why should you choose COUCH Health and our new digital patient recruitment software - TrialVerse? ... COUCH Health are market-leading experts on cultural safety in healthcare, and we can help you to increase patient enrolment from diverse and
-
Rare Disease Day – why it’s important to show your stripes
This collaborative model has proved highly successful, as demonstrated by the natural history registry ACCELERATE (recently published in Cell Reports Medicine); the patient-powered design enabled high enrolment and increased the ... Pharma and biotech
-
Can cultural safety training for sites improve diversity?
We wanted to understand exactly how the healthcare industry was perceived by people from ethnic minority backgrounds, so that we can begin to break down barriers in patient recruitment in these
-
New from the FDA: Diversity in clinical trials guidance summarised
The FDA provides key examples of how to improve study design and conduct to enhance enrolment:. ... Engage with patient advocacy groups, experts and patients, early on in the drug development process.
-
How to lessen site burden with a targeted patient recruitment strategy
You try so hard to increase patient enrolment, yet when the numbers start to rise, the outcome could be the opposite of your intention. ... It all comes down to having a targeted patient recruitment campaign and better pre-screening.
Key benefits of a digital patient recruitment solution
Rare Disease Day – why it’s important to show your stripes
Can cultural safety training for sites improve diversity?
New from the FDA: Diversity in clinical trials guidance summarised
How to lessen site burden with a targeted patient recruitment strategy
More from PMHub
Approximately 0 fully matching, plus 9 partially matching documents found.
COVID-19 Updates and Daily News
Featured jobs
- Editorial Director - UK, , EUROPE, REMOTE.
-
Highly Competitive Salary, Bonus &Benefits
- Senior Account Director, Medical & Brand Communications, Lon...
-
Highly competitive salary
-
CEO Pricing & Market Access, UK
-
Six figure salary
- Account Director, Medical & Brand Communications, London/ SE...
-
Highly competitive salary
- Home Working Medical Copy Writer & Senior Medical Copy Write...
-
Highly Competitive Salary, Bonus &Benefits
- Freelance Scientific Director, Medical Communications, London/ S...
-
Highly competitive salary
- Medical Writers (All levels) Editorial / Scientific Leads & ...
-
Highly Competitive Remuneration packages
- Senior Account Management Trainer, Medical Communications, Londo...
-
Highly competitive salary
- First oral antiviral drug for COVID-19 reviewed by Health Canada
- David Hunt launches independent agency The Considered
- Embattled Biogen talks up Aduhelm
- EU “still interested” in Valneva COVID vaccine despite UK snub
- Havas Life Medicom and ARK lead at 2021 PM Society Digital Awards
- Merck’s anti-COVID drug molnupiravir moves to phase 3 for prevention
- New data for Tecentriq in early-stage lung cancer
- Strong five-year survival data for Kisqali in breast cancer
- A growth mindset frees us to believe that anything is possible
- Live Webinar: Unlocking the Potential of Electronic Medical Records Using Artificial Intelligence
- Queen's Award Highlights Video
- Innovative Trials wins the Queen’s Award
No results were found
PMHub
CSafe Global
CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...
Latest intelligence
- All change – how untangling human behaviour can encourage better health
- Driving better patient outcomes through clear, achievable practical steps that are underpinned by transparent evidence...
- Health literacy in the time of COVID-19
- In a time when much of the media’s focus is on the ongoing COVID-19 pandemic and the differences in vaccination rates between various regions, countries, and socioeconomic groups, improving health...
- Rare thoughts & outcomes - navigating pathways to better outcomes in rare
- ...
